Kim Kardashian and the drug manufacturer Duchesnay are in trouble with the FDA (Food And Drug Administration) over a selfie endorsement Kim posted to her Instagram account. Kim was paid to endorse the morning sickness drug Diclegis, but the selfie allegedly violated several FDA regulations.
According to a letter sent out by the FDA to Duchesnay, the caption on the selfie included the efficacy of the drug, but none of the risks, which are required to be with any drug endorsement, reports NBC News. It’s not immediately clear if the same letter was sent to Kim Kardashian, but after the FDA issued the warning, the endorsement was removed from Kim’s Instagram account.
The photo, which was a close-up of Kardashian holding the medication, received more than 450,000 “likes” – but the FDA didn’t like the image at all. The letter the FDA issued said, in part, “The social media post is misleading because it presents various efficacy claims for Diclegis, but fails to communicate any risk information,” reports NBC News.
The letter from the FDA continued that the photo Kim Kardashian posted “misbrands DICLEGIS” and claims “these violations are concerning from a public health perspective because they suggest that DICLEGIS is safer than has been demonstrated.” The manufacturer responded quickly to the FDA letter and had Kim remove the endorsement.
Although the photo endorsement has been removed, in the caption, Kim Kardashian claimed the medicine made her morning sickness “a lot better,” emphasizing that “most importantly, it’s been studied and there was no increased risk to the baby.” Duchesnay released a statement to news channel CNBC that while Kardashian was paid to promote the drug, Kim was prescribed the medication by her family OB-GYN.
Even though the selfie has been removed, Kim might have to release a second, revised photograph. According to NBC News, the warning letter sent by the FDA also tells Duchesnay they need to “offer corrections to the claims ‘using the same media’ for the same audience.”
The manufacturer also said: “Duchesnay USA takes its regulatory responsibilities very seriously, and acknowledges that its communications, including in social media as in this particular instance, need to be in accordance with applicable rules and regulations.”
According to TMZ, Kim Kardashian has made it clear for the past month that she’s endorsing Diclegis on her various social media accounts, and the manufacturer should have been more aware of FDA regulations regarding social media posts. Even though the post is removed from her account, Kim’s selfie can still be seen all over social media.
[Image credit: Rick Diamond/Getty Images]